Annual Cash & Cash Equivalents
$32.11 M
-$79.86 M-71.32%
December 31, 2023
Summary
- As of February 7, 2025, GOSS annual cash & cash equivalents is $32.11 million, with the most recent change of -$79.86 million (-71.32%) on December 31, 2023.
- During the last 3 years, GOSS annual cash & cash equivalents has fallen by -$453.95 million (-93.39%).
- GOSS annual cash & cash equivalents is now -93.39% below its all-time high of $486.06 million, reached on December 31, 2020.
Performance
GOSS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$28.46 M
-$58.41 M-67.24%
September 30, 2024
Summary
- As of February 7, 2025, GOSS quarterly cash and cash equivalents is $28.46 million, with the most recent change of -$58.41 million (-67.24%) on September 30, 2024.
- Over the past year, GOSS quarterly cash and cash equivalents has dropped by -$3.65 million (-11.35%).
- GOSS quarterly cash and cash equivalents is now -94.14% below its all-time high of $486.06 million, reached on June 30, 2020.
Performance
GOSS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GOSS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.3% | -11.3% |
| 3 y3 years | -93.4% | -86.7% |
| 5 y5 years | -69.5% | -78.2% |
GOSS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.5% | at low | -84.5% | at low |
| 5 y | 5-year | -93.4% | at low | -94.1% | at low |
| alltime | all time | -93.4% | >+9999.0% | -94.1% | +8936.2% |
Gossamer Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $28.46 M(-67.2%) |
| Jun 2024 | - | $86.88 M(+123.5%) |
| Mar 2024 | - | $38.86 M(+21.0%) |
| Dec 2023 | $32.11 M(-71.3%) | $32.11 M(-61.1%) |
| Sep 2023 | - | $82.61 M(+123.2%) |
| Jun 2023 | - | $37.00 M(-43.3%) |
| Mar 2023 | - | $65.24 M(-41.7%) |
| Dec 2022 | $111.97 M(-38.9%) | $111.97 M(-27.0%) |
| Sep 2022 | - | $153.48 M(+62.7%) |
| Jun 2022 | - | $94.32 M(-32.1%) |
| Mar 2022 | - | $138.91 M(-24.3%) |
| Dec 2021 | $183.40 M | $183.40 M(-14.1%) |
| Sep 2021 | - | $213.47 M(-37.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $342.45 M(-22.1%) |
| Mar 2021 | - | $439.66 M(-9.5%) |
| Dec 2020 | $486.06 M(+260.0%) | $486.06 M(+5.2%) |
| Sep 2020 | - | $461.96 M(-5.0%) |
| Jun 2020 | - | $486.06 M(+336.5%) |
| Mar 2020 | - | $111.35 M(-17.5%) |
| Dec 2019 | $135.03 M(+28.3%) | $135.03 M(+3.3%) |
| Sep 2019 | - | $130.71 M(-12.0%) |
| Jun 2019 | - | $148.50 M(-13.1%) |
| Mar 2019 | - | $170.85 M(+62.4%) |
| Dec 2018 | $105.22 M(>+9900.0%) | $105.22 M(-25.4%) |
| Sep 2018 | - | $141.07 M(>+9900.0%) |
| Dec 2017 | $315.00 K(+425.0%) | $315.00 K |
| Dec 2016 | $60.00 K | - |
FAQ
- What is Gossamer Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Gossamer Bio?
- What is Gossamer Bio annual cash & cash equivalents year-on-year change?
- What is Gossamer Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Gossamer Bio?
- What is Gossamer Bio quarterly cash and cash equivalents year-on-year change?
What is Gossamer Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of GOSS is $32.11 M
What is the all time high annual cash & cash equivalents for Gossamer Bio?
Gossamer Bio all-time high annual cash & cash equivalents is $486.06 M
What is Gossamer Bio annual cash & cash equivalents year-on-year change?
Over the past year, GOSS annual cash & cash equivalents has changed by -$79.86 M (-71.32%)
What is Gossamer Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GOSS is $28.46 M
What is the all time high quarterly cash and cash equivalents for Gossamer Bio?
Gossamer Bio all-time high quarterly cash and cash equivalents is $486.06 M
What is Gossamer Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, GOSS quarterly cash and cash equivalents has changed by -$3.65 M (-11.35%)